Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats

Journal of Cerebral Blood Flow and Metabolism

Volumn 13, Issue 4, 1993, Pages 702-711

  Scremin, Oscar U ^a,c   Erika Scremin, A M ^a   Heuser, Deborah ^a   Hudgell, Raymond ^a   Romero, Elsa ^a   Imbimbo, Bruno P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Mediolanum Farmaceutici   (Italy)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Acetylcholine; Cerebral glucose utilization; Cerebro vascular circulation; Cholinesterase inhibitors; Physostigmine

Indexed keywords

CHOLINESTERASE INHIBITOR; EPTASTIGMINE; GLUCOSE; HEPTYLSTIGMINE TARTRATE; PHYSOSTIGMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN METABOLISM; BRAIN PERFUSION; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GLUCOSE BRAIN LEVEL; GLUCOSE UTILIZATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ANIMAL; BRAIN; CEREBROVASCULAR CIRCULATION; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; MALE; PHYSOSTIGMINE; RATS; RATS, WISTAR; REFERENCE VALUES; REGRESSION ANALYSIS; TIME FACTORS;

EID: 0027159190     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.1993.89     Document Type: Article

References (50)

1. 2 responsiveness. J Neurosurg 43:689-705
2. Aubineau P, Sercombe R, Edvinsson L, Owman C (1977) Cholinergic influence on the cerebrovascular bed mediated through actions on the vascular smooth musculature and on the perivascular sympathetic nerves. In: Neurogenic Control of the Brain Circulation (Owman C. Edvinsson L, eds) New York, Pergamon Press, pp 331-342
3. Bartlett MS (1947) The use of transformations. Biometrics 3:39-52
4. Bernhatrdson CS (1975) Type I error rates when multiple comparison procedures follow a significant F test of ANOVA Biometrics 31:229-232
5. Brufani M, Marta M, Pomponi M (1986) Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementia. Eur J Biochem 157:115-120
6. Brufani M, Castellano C, Marta M, Oliverio A, Pagella PG, Pavone F, Pomponi M, Rugarli PL (1987) A long-lasting cholinesterase inhibitor affecting neural and behavioral processes. Pharmacol Biochem Behav 26:625-629
7. Carmer SG, Swanson MR (1973) An evaluation of ten pairwise multiple comparison procedures by Monte Carlo methods. J Am Stat Assoc 68:66-74
8. Dawson GR, Bentley G, Draper F, Rycroft W, Iversen SD. Pagella PG (1991) The behavioral effects of heptylphysostigmine, a new cholinesterase inhibitor, in tests of long term and working memory in rodents (Abstract). Pharmacol Biochem Behav 39:865-871
9. De Sarno P, Pomponi M, Giacobini E, Tang XC, Williams E (1989) The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat. Neurochem Res 14:971-977
10. Edvinsson L, Falck B, Owman C (1977) Possibilities for a cholinergic action on smooth musculature and on sympathetic axons in brain vessels mediated by muscarinic and nicotinic receptors. J Pharmacol Exp Ther 200:117-126
11. Florence VM, Bevan JA (1979) Biochemical determination of cholinergic innervation in cerebral arteries. Circ Res 45:212-218
12. Heistad DD, Kontos HA (1983) Cerebral circulation. In: The Cardiovascular System, Vol 3, Peripheral Circulation and Organ Blood Flow (Shepherd JT, Abboud FM, eds) Bethesda, American Physiological Society, pp 137-182
13. Kuschinsky W, Wahl M, Neiss A (1974) Evidence for cholinergic dilatatory receptors in pial arteries of cats. Pflügers Arch 347:199-208
14. Linville DG, Giacobini E, Arneric SP (1992) Heptylphysostigmine enhances basal forebrain control of cortical cerebral blood flow. J Neurosci Res 31:573-577
15. Maiese K, Holloway HW, Larson DM, Reis DJ, Soncrant TT (1991) Coupling of regional cerebral metabolism and blood flow in the conscious rat is maintained after treatment with the muscarinic agonist arecoline. Soc Neurosci Abstr 17:26
16. Marta M, Castellano C, Oliverio A, Pavone F, Pagella PG, Brufani M, Pomponi M (1988) New analogs of physostigmine: alternative drugs for Alzheimer's disease? Life Sci 43:1,921-1,928
17. McCulloch J, Kelly PAT, Ford I (1982) Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis). J Cereb Blood Flow Metab 2:487-499
18. Molnar L, Hegedus K, Fekete I (1991) Difference between the cerebrovascular effect of purinergic Co-ATP and that of the cholinesterase inhibitor, physostigmine, in vivo. Eur J Pharmacol 209:81-86
19. Paxinos G, Watson C (1982) The Rat Brain in Stereotaxic Coordinates. Sidney, Academic Press
20. Rovere AC, Scremin OU, Beresi MR, Raynald AC, Giardini A (1973) Cholinergic mechanism in the cerebrovascular action of carbon dioxide. Stroke 4:969-912
21. Rupniak NMJ, Tye SJ, Brazell C, Heald A, Iversen SD, Pagella PG (1992) Reversal of cognitive impairment by heptylphysostigmine, a long lasting cholinesterase inhibitor, in primates. J Neurol Sci 107:246-249
22. Saito GA, Wu JY, Lee TJF (1985) Evidence for the presence of cholinergic nerves in cerebral arteries: an immunohistochemical demonstration of choline acetyltransferase. J Cereb Blood Flow Metab 5:327-334
23. 14C]antipyrine. Am J Physiol 234:H59-H66
24. Schuier F, Orzi F, Suda S, Lucignani G, Kennedy D, Sokoloff L (1990) Influence of plasma glucose concentration on lumped constant of the deoxyglucose method: effects of hyperglycemia in the rat. J Cereb Blood Flow Metab 10:765-773
25. Scremin OU (1991) Pharmacological control of the cerebral circulation. Annu Rev Pharmacol Toxicol 31:229-251
26. Scremin OU, Scremin AME (1986) Physostigmine induced reversal of ischemia following middle cerebral artery occlusion in the rat. Stroke 17:1,004-1,009
27. Scremin OU, Shih T (1991) Cerebral blood flow-metabolism coupling after administration of soman at nontoxic levels. Brain Res Bull 26:353-356
28. Scremin OU, Rovere AA, Raynald AC, Giardini A (1973) Cholinergic control of blood flow in the cerebral cortex of the rat. Stroke 4:232-239
29. 2 reactivity: role of a cholinergic mechanism modulated by anesthesia. Stroke 9:160-165
30. Scremin OU, Sonnenschein RR, Rubinstein EH (1982) Cholinergic cerebral vasodilatation in the rabbit: absence of concomitant metabolic activation. J Cereb Blood Flow Metab 2:241-247
31. Scremin OU, Sonnenschein RR, Rubinstein EH (1983) Cholinergic cerebral vasodilatation: lack of involvement of cranial parasympathetic nerves. J Cereb Blood Flow Metab 3:362-368
32. Scremin AME, Allen K, Scremin OU (1988a) Regional distribution of the cerebral vasodilatation induced by a cholinergic agonist (Abstract). FASEB J 2:A722
33. Scremin OU, Allen K, Torres CD, Scremin AME (1988b) Physostigmine enhances blood flow metabolism ratio in neocortex. Neuropsychopharmacology 1:297-303
34. Scremin OU, Scremin AME, Somani SM, Giacobini E (1990) Brain regional distribution of physostigmine and its relation to cerebral blood flow following intravenous administration in rats. J Neurosci Res 26:188-195
35. Scremin AME, Kunkel CF, Eisenberg B, Elliot T, Scremin OU (1992) Physostigmine improves cerebral blood flow in human focal cerebral ischemia. J Stroke Cerebrovasc Dis 2:87-91
36. Shaw KP, Aracava Y, Akaike A, Daly JW, Rickett DL, Albuquerque EX (1985) The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Mol Pharmacol 28:527-538
37. Shin T-M, Koviak TA, Capacio BR (1991) Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci Biobehav Rev 15:349-362
38. 14]-deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 28: 897-916
39. Somani SM, Dube SN (1989) Physostigmine: an overview as pretreatment drug for organophosphate intoxication. Int J Clin Pharmacol Ther Toxicol 27:367-387
40. Suzuki N, Hardebo JE, Owman C (1990) Origin and pathways of choline acetyltransferase-positive parasympathetic nerve fibers to cerebral vessels in rats. J Cereb Blood Flow Metab 10:399-408
41. Taylor P (1990) Anticholinesterase agents. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics (Goodman Gilman A, Rall TW, Nies AS, Taylor P, eds) New York, Pergamon Press, pp 131-149
42. Triguero D, López de Pablo AL, Gómez B, Estrada C (1988) Regional differences in cerebrovascular cholinergic innervation in goats. Stroke 19:736-740
43. Unni LK, Hutt V, Imbimbo BP, Becker RE (1991) Kinetics of cholinesterase inhibition by eptastigmine in man. Eur J Clin Pharmacol 41:83-84
44. Wilkinson L (1986) SYSTAT: the system for statistics. Evanston, IL, SYSTAT Inc.
45. Wilson IB, Hatch MA, Ginsburg S (1960) Carbamylation of acetylcholinesterase. J Biol Chem 235:2,312-2,315
46. Woolf NJ, Butcher LL (1985) Cholinergic systems in the rat brain. II. Projections to the interpeduncular nucleus. Brain Res Bull 14:63-83
47. Woolf NJ, Butcher LL (1986) Cholinergic systems in the rat brain. III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia and basal forebrain. Brain Res Bull 16:603-637
48. Woolf NJ, Butcher LL (1989) Cholinergic systems in the rat brain. IV. Descending projections of the pontomesencephalic tegmentum. Brain Res Bull 23:519-540
49. Woolf NJ, Eckenstein F, Butcher LL (1983) Cholinergic projections from the basal forebrain to the frontal cortex: a combined fluorescent tracer and immunohistochemical analysis in the rat. Neurosci Lett 40:93-98
50. Woolf NJ, Eckenstein F, Butcher LL (1984) Cholinergic systems in the rat brain. I. Projections to the limbic telencephalon. Brain Res Bull 13:751-784